VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
0.1223
+0.0016 (1.33%)
At close: Jun 23, 2026, 4:00 PM EDT
0.121086
-0.0012 (-0.99%)
After-hours: Jun 23, 2026, 7:25 PM EDT
Company Description
VSee Health, Inc. provides telehealth care solutions in the United States.
The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions.
It also provides telehealth software building blocks, such as patient engagement, clinician staffing, remote physical exam and remote patient monitoring, and AI for telesitter and telenursing solutions; data connectors; and workflow templates.
The company distributes its products through third-party resellers and affiliated hospitals, as well as sales executives.
The company is headquartered in Newton, Massachusetts.
VSee Health, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 209 |
| CEO | Imoigele Aisiku |
Contact Details
Address: One Gateway Center, Suite 507 Newton, Massachusetts 02458 United States | |
| Website | vseehealth.com |
Stock Details
| Ticker Symbol | VSEE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1864531 |
| CUSIP Number | 92919Y102 |
| ISIN Number | US92919Y1029 |
| Employer ID | 86-2970927 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Dr. Imoigele P. Aisiku M.B.A., M.D. | Co-Chief Executive Officer and Director |
| Jerry Leonard CPA, M.B.A. | Chief Financial Officer, Senior Vice President and Secretary |
| Erika Chuang Ph.D. | Chief of Products |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 11, 2026 | 424B3 | Prospectus |
| Jun 11, 2026 | 8-K | Current Report |
| Jun 11, 2026 | 8-K | Current Report |
| Jun 10, 2026 | 424B3 | Prospectus |
| Jun 5, 2026 | 8-K | Current Report |
| May 29, 2026 | 424B3 | Prospectus |
| May 15, 2026 | 10-Q | Quarterly Report |
| May 15, 2026 | SCHEDULE 13G/A | Filing |
| Apr 2, 2026 | 424B3 | Prospectus |
| Apr 2, 2026 | POS EX | Filing |